Shareholders' Equity

9 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Shareholders' Equity

17. Shareholders’ Equity

In May 2019, the Company’s Board of Directors approved a Common Stock repurchase authorization for which there was remaining authority to repurchase 4,109,419 shares of Common Stock as of May 3, 2022. On May 3, 2022, the Board of Directors increased the Common Stock repurchase authorization by 7,890,581 shares to 12,000,000 shares as of that date. As of September 30, 2024, the Company had remaining authority to repurchase 10,720,477 shares of Common Stock.

Changes to the Company's common shares outstanding were as follows (in shares):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2024			2023			2024			2023
Outstanding at beginning of period		65,154,082			65,298,085			65,473,807			65,472,148
Repurchases of Common Stock		(100,212	)		-			(564,405	)		(265,795	)
Exercise of stock options		175			81,434			49,800			118,201
Payment of stock-based restricted and performance shares		16,346			4,099			183,661			93,765
Shares tendered for taxes on stock-based compensation		(7,571	)		(1,925	)		(86,606	)		(44,335	)
Other		-			-			6,563			7,709
Outstanding at end of period		65,062,820			65,381,693			65,062,820			65,381,693